Literature DB >> 8792938

On the use of paramagnetic beads and ferrofluids to assess and eliminate the leukocytic contribution to oxygen radical generation by human sperm suspensions.

R J Aitken1, D W Buckingham, K West, J Brindle.   

Abstract

PROBLEM: To develop a methodology to determine a) the leukocytic contribution to reactive oxygen species generation by human sperm suspensions and b) the therapeutic value of removing these cellular contaminants.
METHODS: Leukocytes were removed with paramagnetic beads or colloidal ferrofluids coated with anti-CD45 antibody. The sperm suspensions were monitored for oxidant generation by chemiluminescence, leukocyte contamination by immunocytochemistry, and fertilizing potential using zona-free hamster oocytes.
RESULTS: Percoll -prepared human sperm suspensions exhibited a competence for PMA-induced reactive oxygen species generation which was significantly correlated with leukocyte contamination. However, the purified spermatozoa remaining after paramagnetic bead treatment, also demonstrated an intrinsic capacity for PMA-responsive reactive oxygen species generation and, freed from the oxidative stress created by the leukocytes, exhibited a significantly enhanced capacity for sperm-oocyte fusion.
CONCLUSIONS: Although human spermatozoa can generate reactive oxygen species, sperm function is inhibited by the additional oxidative stress created by contaminating leukocytes. Removal of these cells with paramagnetic beads enhances fertilizing potential.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792938     DOI: 10.1111/j.1600-0897.1996.tb00055.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  10 in total

1.  Extending the coincubation time of gametes improves in vitro fertilization.

Authors:  W R Boone; J E Johnson
Journal:  J Assist Reprod Genet       Date:  2001-01       Impact factor: 3.412

Review 2.  Apoptosis and DNA damage in human spermatozoa.

Authors:  R John Aitken; Adam J Koppers
Journal:  Asian J Androl       Date:  2010-08-30       Impact factor: 3.285

3.  Effects of reducing insemination time in human in vitro fertilization and embryo development by using sibling oocytes.

Authors:  S Coskun; G L Roca; A M Elnour; H al Mayman; J M Hollanders; K A Jaroudi
Journal:  J Assist Reprod Genet       Date:  1998-11       Impact factor: 3.412

Review 4.  New insights into male (in)fertility: the importance of NO.

Authors:  B Buzadzic; M Vucetic; A Jankovic; A Stancic; A Korac; B Korac; V Otasevic
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 5.  Use of diagnostic testing to detect infertility.

Authors:  Kathleen Hwang; Larry I Lipshultz; Dolores J Lamb
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 6.  Contemporary concepts in the evaluation and management of male infertility.

Authors:  Kathleen Hwang; R Chanc Walters; Larry I Lipshultz
Journal:  Nat Rev Urol       Date:  2011-01-18       Impact factor: 14.432

7.  The in vitro effects of superoxide, some commercially available antioxidants and red palm oil on sperm motility.

Authors:  Yapo Guillaume Aboua; Stefan Stephanus du Plessis; Patricia Reichgelt; Nicole Brooks
Journal:  Asian J Androl       Date:  2009-10-05       Impact factor: 3.285

Review 8.  The Importance of Oxidative Stress in Determining the Functionality of Mammalian Spermatozoa: A Two-Edged Sword.

Authors:  Robert J Aitken; Joel R Drevet
Journal:  Antioxidants (Basel)       Date:  2020-01-27

9.  Cyclic FEE Peptide Improves Human Sperm Movement Parameters without Modification of Their Energy Metabolism.

Authors:  Nathalie Le Foll; Jean-Christophe Pont; Audrey L'Hostis; Thomas Guilbert; Frédéric Bouillaud; Jean-Philippe Wolf; Ahmed Ziyyat
Journal:  Int J Mol Sci       Date:  2021-10-19       Impact factor: 5.923

Review 10.  The Role of Genetics and Oxidative Stress in the Etiology of Male Infertility-A Unifying Hypothesis?

Authors:  Robert John Aitken; Mark A Baker
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.